Product Description: VCP-Eribulin consists the ADCs linker (VCP) and Eribulin[1]. Eribulin is a mechanistically unique microtubule inhibitor for cancer[2]. VCP-Eribulin is an Eribulin-based agent for antibody conjugates[1].
Applications: Cancer-programmed cell death
Formula: C59H86N6O16
References: [1]Earl F Albone, et al. Eribulin-based antibody-drug conjugates and methods of use. US20170252458A1./[2]Towle MJ, et al. Eribulin induces irreversible mitotic blockade: implications of cell-based pharmacodynamics for in vivo efficacy under intermittent dosing conditions. Cancer Res. 2011 Jan 15;71(2):496-505.